DICE Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $88,221,000.
Profit Margin
| 2019 | 5.77M | -12.96M | -224.48% |
|---|---|---|---|
| 2020 | 863K | -23.75M | -2752.26% |
| 2021 | 1.12M | -48.47M | -4308.62% |
| 2022 | 0 | -81.66M |
DICE Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 1.12M | 863K | 5.77M |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 1.12M | 863K | 5.77M |
Operating exp. | ||||
Research and development | 62.55M | 36.50M | 19.58M | 15.71M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 88.22M | 48.72M | 24.58M | 19.32M |
Operating income | -88.22M | -47.60M | -23.72M | -13.54M |
Other income (expenses), net | 4.33M | -1.35M | -18K | 609K |
Income before tax | -83.88M | -48.95M | -23.73M | -12.93M |
Income tax expense | -2.22M | -487K | 13K | 26K |
Net income | -81.66M | -48.47M | -23.75M | -12.96M |
Earnings per share | ||||
Basic EPS | -2.07 | -3.91 | -1.02 | -0.56 |
Diluted EPS | -2.07 | -3.91 | -1.02 | -0.56 |
| Data source | Data source |